Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 18/20 | 0.59 |
| ▸ | PDE4A | P27815 | 17/20 | 0.59 |
| ▸ | PDE4C | Q08493 | 17/20 | 0.59 |
| ▸ | PDE4D | Q08499 | 17/20 | 0.59 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7862283 | 1.00 | PDE4B (0.59) | PDE4BPDE4APDE4CPDE4DSLC6A4 | |
| SCHEMBL7862294 | 1.00 | PDE4B (0.59) | PDE4BPDE4APDE4CPDE4DSLC6A4 | |
| SCHEMBL7400233 | 0.87 | PDE4B (0.59) | PDE4BPDE4APDE4CPDE4DSLC6A4 | |
| SCHEMBL7400235 | 0.87 | PDE4B (0.59) | PDE4BPDE4APDE4CPDE4DSLC6A4 | |
| SCHEMBL7499426 | 0.87 | PDE4B (0.62) | PDE4BPDE4APDE4CPDE4DSLC6A4 | |
| SCHEMBL6546408 | 0.87 | PDE4B (0.64) | PDE4BPDE4APDE4CPDE4D | |
| SCHEMBL7416969 | 0.84 | PDE4B (0.66) | PDE4BPDE4APDE4CPDE4D | |
| SCHEMBL7417971 | 0.84 | PDE4B (0.74) | PDE4BPDE4APDE4CPDE4D | |
| SCHEMBL7863406 | 0.84 | PDE4B (0.66) | PDE4BPDE4APDE4CPDE4D | |
| SCHEMBL7862312 | 0.84 | PDE4B (0.74) | PDE4BPDE4APDE4CPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6300372-B1 | USED IN THERAPY OF ALLERGIC AND INFLAMMATORY DISEASES AND FOR INHIBITING THE PRODUCTION OF TUMOR NECROSIS FACTOR (TNF) | SMITHKLINE BEECHAM CORPORATION | 2001-10-09 | — | — | US | claimed |
| US-6300372-B1 | USED IN THERAPY OF ALLERGIC AND INFLAMMATORY DISEASES AND FOR INHIBITING THE PRODUCTION OF TUMOR NECROSIS FACTOR (TNF) | SMITHKLINE BEECHAM CORPORATION | 2001-10-09 | — | — | US | disclosed |